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Abstract
 
The development of an immune response critically relies on the encounter of rare antigen
(Ag)-specific T cells with dendritic cells (DCs) presenting the relevant Ag. How two rare cells
find each other in the midst of irrelevant other cells in lymph nodes (LNs) is unknown. Here
we show that initial T cell activation clusters are generated near high endothelial venules
(HEVs) in the outer paracortex of draining LNs by retention of Ag-specific T cells as they exit
from HEVs. We further show that tissue-derived DCs preferentially home in the vicinity of
HEVs, thus defining the site of cluster generation. At this location DCs efficiently scan all incoming
T cells and selectively retain those specific for the major histocompatibility complex–peptide
complexes the DCs present. Such strategic positioning of DCs on the entry route of T cells
into the paracortex may foster T cell–DC encounter and thus optimize initial T cell activation
in vivo.
Key words: T cell activation • dendritic cells • imaging • in vivo
 
Introduction
 
A critical event in the initiation of an immune response is
the encounter of Ag-specific T cells with DCs that present
the Ag of interest. Confronted with the low frequency of
the two protagonists, the immune system has evolved efficient
strategies for the two cell types to meet within organized
lymphoid organs. On one hand, lymphocytes continuously
patrol the entire body, achieving a complete tour of the
lymphatic system within 24 h (1). On the other hand, DCs
that pick up the Ag at the site of infection are stimulated by
pathogen-derived signals to migrate through the afferent
lymph toward the draining LNs (2). Although this strategy
clarifies how the two cell types concentrate within one
limited anatomical site, it still does not explain how Ag-
specific T cells and relevant DCs find each other in the
midst of millions of irrelevant cells present in the LN.
It has been proposed that appropriate anatomical location
might be determined by changes of expression of chemo-
kines and chemokine receptors during DC maturation (3).
Stimulation by TNF-
 
 
 
, microbial products, or CD40 induces
in DCs a redistribution of MHC molecules, expression of
high level of costimulatory molecules, and thus maturation
of DCs into potent stimulators of naive T cells (4). These
maturation signals also induce in immature DCs the expres-
sion of the LN homing chemokine receptor CCR7, itself
instructing trafficking of the DCs toward the LN (5–8). In
addition, mature DCs express CCL19 (MIP-3
 
 
 
, ELC) and
CCL21 (SLC), the ligands for CCR7, and may therefore
attract naive and memory T cells within LNs (5). Because
all naive T cells express CCR7, simple chemoattraction
would appear inefficient, as all T cells within the LN would
have to survey the entire LN and scan all activated DCs.
An alternative model was proposed by Gretz et al. (9). Ultra-
structural studies of LN paracortex suggest that high endo-
thelial venules (HEVs) are part of organized structures: the
paracortical cords. Thus, HEVs are at one end of a corridor
that T cells would be obliged to take when crossing the endo-
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thelial barrier and gaining access to the paracortex. Gretz et
al. (9) proposed that DCs settle within the corridors in the
proximity of HEVs and there, as gatekeepers, scan all in-
coming T cells selectively retaining those that express a rel-
evant TCR. This strategic location should permit more ef-
ficient recruitment of Ag-specific T cells into the immune
response. Such organized routing of T cells is, however,
questioned by the recent observation that T cells migrate
randomly into intact LNs (10–13).
In this study, we report on the anatomy and mechanisms
of initial T cell activation within the LN. We show by
confocal microscopy that DCs that have picked up Ag
within the skin preferentially locate in the vicinity of
HEVs. We further show that this strategic location allows
for an efficient scanning of incoming T cells and selective
retention and activation of Ag-specific T cells. These re-
sults suggest a novel strategy that the immune system may
have developed to optimize encounter of rare Ag-specific
T cells and DCs presenting the Ag of interest.
 
Materials and Methods
 
Mice.
 
The 3A9 mice are transgenic for a TCR specific for the
hen egg lysozyme (HEL) peptide 46–61 presented by I-A
 
k 
 
(14).
The 3A9 mice were maintained on a CBA/J background and for
adoptive transfer, crossed with B10.BR Ly5.1
 
  
 
congenic mice.
 
Cells and Adoptive Transfer.
 
CD4
 
  
 
T cells were purified from
the LN of 3A9 transgenic mice by negative selection as previously
described (15). On average, the population recovered was com-
posed of 
 
 
 
90% CD4
 
  
 
T cells of which 
 
 
 
3% were CD44
 
 
 
. The
cells were labeled with 5-(and-6)-carboxyfluorescein diacetate
succinimidyl ester (CFSE; Molecular Probes) or orange fluores-
cent tetramethylrhodamine (CMTMR) as previously described
(15). (CBA/J
 
 
 
B10.BR)F1 recipient mice were injected intrave-
nously with 2 
 
  
 
10
 
6 
 
wild-type (W) or 3A9 CD4
 
  
 
T cells.
 
Generation of DCs.
 
DCs were derived from BM by culture
for 7 d in RPMI supplemented with 10% FCS, antibiotics, 2 mM
glutamine, 50 
 
 
 
M 2-ME, and 30% conditioned medium from
GM-CSF transfected NIH3T3 cells, as previously described (16,
17). Nonadherent DCs were harvested, incubated overnight with
3 
 
 
 
M peptide (pigeon cytochrome c [PCC] 88–104 or HEL 46–
61), and 10
 
6 
 
peptide-loaded DCs were injected into the footpads
of recipient mice. 80% of the nonadherent cells are DC based on
CD11c expression and express CD11b but not CD8
 
  
 
and B220.
 
Immunization.
 
Green (505/515) or red (580/605) fluorescent,
40 nm FluoSpheres
 
®
 
 Neuravidin™-labeled microspheres were in-
cubated with biotinylated HEL (Sigma-Aldrich) or BSA (Sigma-
Aldrich). The mice were immunized by subcutaneous injection
in the hind footpads with 
 
 
 
0.1 
 
  
 
10
 
9 
 
HEL or BSA microspheres
emulsified in CFA in a 10-
 
 
 
l volume or with 30 
 
 
 
g native HEL
protein emulsified in CFA.
 
Antibodies and Flow Cytometry.
 
The anti-CD11c (HL-3),
anti-CD11b (M1.70), anti-Ly5.1 (A20), anti-CD8
 
  
 
(53.6.7),
anti-B220 (RA36B2), and anti-CD4 (RM4–5) Ab were pur-
chased from BD Biosciences. These antibodies were directly cou-
pled to allophycocyanin, PE, FITC, or biotin, in which case
staining was revealed using streptavidin-PE or streptavidin-allo-
phycocyanin (BD Biosciences).
 
Immunostaining.
 
LNs were fixed overnight in medium con-
taining 0.05 M phosphate buffer, 0.1 M 
 
l
 
-lysine, pH 7.4, 2 mg/ml
NaIO4, and 10 mg/ml paraformaldehyde, and then dehydrated in
 
consecutive sucrose gradients (10, 20, and 30% in phosphate
buffer). Tissues were snap frozen in Tissue-Tek
 
® 
 
(Sakura Finetek).
8 
 
 
 
m frozen sections were stained with either FITC or allophyco-
cyanin anti-B220 Ab (RA36B2), Alexa Fluor 488 phalloidin
(Molecular Probes), unconjugated anti–peripheral LN addressin
(PNAd) Ab (MECA-79), or anti-CD25 Ab (PC61) as previously
described (18). PNAd and CD25 staining was revealed with an Al-
exa Fluor 647 goat anti–rat IgG (Molecular Probes). Immunofluo-
rescence confocal microscopy was performed with Leica TCS 4D
and Zeiss LSM 510 confocal microscopes. Separate images were
collected for each fluorochrome and overlaid to obtain a multi-
color image. LNs were scanned and the different images were jux-
taposed to reconstitute a whole LN. Final image processing was
performed using Adobe Photoshop. Quantitative analysis of T cell
distribution into LN sections was performed using ImageJ software
(National Institutes of Health). For each section the deep paracor-
tex zone, excluding most HEVs, and the outer paracortex zone,
including most HEVs, were defined manually. The number of cells
present in each zone was then calculated by image processor. Al-
ternatively, the distance between each individual DC or T cell and
the most proximal HEV was determined as follows. The x and y
coordinates of DCs, T cells, and HEVs were determined using Im-
ageJ software. The minimal euclidean distance (D
 
i
 
) was calculated
with the following equation: D
 
i 
 
  
 
min
 
j 
 
{
 
√
 
[(x
 
i
 
 
 
x
 
j
 
)
 
2 
 
  
 
(y
 
i
 
 
 
y
 
j
 
)
 
2
 
]},
where i 
 
  
 
1 . . . n (DC); j 
 
  
 
1 . . . n (HEV) and min is the mini-
mum function. Distance intervals were defined and the percentage
of cells within each interval were calculated.
 
Online Supplemental Material.
 
Figs. S1 and S2 are available at
http://www.jem.org/cgi/content/full/jem.20030167/DC1. Fig.
S1 shows T cell transit through the paracortical cord surrounding
the HEV when accessing the paracortex. Fig. S2 shows homing
of BM-derived DCs near HEVs in draining LNs.
 
Results
 
Initial T Cell Activation Takes Place Near HEVs.
 
To vi-
sualize the early phase of T cell activation in vivo, we used
an adoptive transfer system in which CFSE-labeled TCR
transgenic T cells (3A9) specific for 46–61 HEL peptide
presented by I-A
 
k 
 
were injected into syngenic hosts. The
fluorescent dye CFSE permits both imaging of T cells
within the LN by confocal microscopy and examination of
T cell division through FACS
 
® 
 
analysis of CFSE dilution.
The recipient mice were primed 24 h after adoptive trans-
fer by subcutaneous injection of HEL protein emulsified in
CFA. As expected, in naive mice or mice injected with
CFA only, the 3A9 T cells scattered within the T cell areas
of the LN (Fig. 1 a, A and C, and not depicted). Starting
around 16 h and clearly evident by 24 h after injection,
3A9 T cells relocalized in the outer part of the paracortex,
just beneath the B cell zone in Ag-draining LNs (Fig. 1 a,
B). The pattern suggests a clustering, potentially around
DCs in a restricted area of the paracortex. This restricted
localization is transient, lasting for around 20 h, and then T
cells distributed into the T cell zone (Fig. 1 a, D). At this
time point most 3A9 T cells have divided several times as
evidenced by CFSE dilution (Fig. 1 a, D, inset). To ensure
that initial activation of the Ag-specific T cells occurs
within the observed clusters, we analyzed CD25 expression
by 3A9 T cells, a receptor that is induced rapidly and tran-T
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siently after TCR engagement (19). As a control for the Ag
specificity of the activation process we cotransferred 3A9
transgenic T cells and nontransgenic wild-type CD4 T
cells. In addition, to synchronize T cell activation, mice
were first immunized with HEL protein and then, 24 h
later, adoptively transferred with CMTMR-labeled 3A9
and CFSE-labeled nontransgenic CD4 T cells. Expression
of CD25 was analyzed by immunohistology 24 h after T
cell transfer (Fig. 1 b). Some recipient LN cells, likely cor-
responding to the regulatory CD4
 
  
 
CD25
 
  
 
T cells and
T cells specific for environmental pathogens, expressed
CD25. Regardless of the immunization regiment, the non-
transgenic CD4 T cells did not up-regulate CD25 expres-
sion. Likewise, in CFA-injected mice the 3A9 T cells re-
mained CD25
 
 
 
. In contrast, in HEL-immunized mice
most 3A9 T cells present in clusters expressed CD25 and
showed increased size indicating that they were activated.
Therefore, initial T cell activation does not take place ran-
domly within the paracortex where most T cells scatter,
but rather in the outer paracortex, in boundary areas be-
tween the B cell and T cell zone.
Structural analyses indicate that HEVs are primarily lo-
cated near the B cell zone in the paracortex of LNs (20). To
examine the possibility that clusters accumulated near HEVs
Figure 1. Visualization of 3A9  CD4  T cell activation in situ. (a) CFSE-labeled 3A9  CD4 T cells (green) were injected into recipient mice as de-
scribed in Materials and Methods. 24 h later, mice were primed in the footpad with CFA (A–C) or CFA plus HEL (B–D). Draining popliteal LNs were
harvested 24 or 48 h after immunization and analyzed by confocal microscopy. The B cell zones defined on sections as areas rich in B220  cells appear in
blue. Division of 3A9  CD4 T cells was evaluated by FACS® analysis of CFSE dilution (inset in C and D). (b) Recipient mice were injected with CFA
or CFA plus HEL 24 h before transfer of CMTMR-labeled 3A9 T cells (red) and CFSE-labeled nontransgenic T cells (blue). Draining LNs were har-
vested 24 h after T cell transfer and analyzed by confocal microscopy after staining with anti-CD25 Ab (green). 2 representative clusters of 3A9 T cells in
sections of 2 different LNs, out of 14 analyzed, are shown for HEL-injected mice.
Figure 2. Initial CD4  T cell activation clusters localize near HEVs. (a) Mice were adoptively transferred with CMTMR-labeled 3A9  CD4 T cells
(red) and then primed 24 h later with CFA (A) or CFA plus HEL (B). Draining LNs were harvested 24 h after immunization. Sections were analyzed by
confocal microscopy after staining with a B cell–specific (green) and an anti-PNAd Ab that specifically reacts with HEVs (blue). (b) The percentage of
3A9 T cells present within or outside the deep paracortex defined by the dashed line in (a) was counted as described in Materials and Methods. The mean
percentage and SD of 9 and 14 individual LNs isolated from either CFA- or CFA/HEL-injected mice, respectively, is presented.T
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we stained sections with an Ab specific for the PNAd that is
selectively found on the luminal phase of HEVs (21). As an-
ticipated, clusters of Ag-specific T cells were preferentially
found near and around HEVs (Fig. 2 a, B). To substantiate
our observation we quantified T cell localization in the LNs
of immunized and unimmunized mice. We delineated two
areas within the LN paracortex corresponding to the deep
paracortex excluding most HEVs and the outer paracortex
where most HEVs are found, and counted the number of T
cells within each zone (Fig. 2 a). In CFA-injected mice,
3A9 T cells segregated equally within the two zones reflect-
ing the rate of basal trafficking within the nodes (Fig. 2 b).
 
In HEL-injected mice, 74.5 
 
  
 
6.4% (mean 
 
  
 
SD, 
 
n 
 
  
 
14)
of the 3A9 T cells were found in the outer paracortex (Fig.
2 b). Therefore, the 3A9 T cells appear selectively trapped
in the outer paracortex near HEVs, in Ag-draining LNs.
This confinement suggests that clusters are not formed by
the Ag-specific T cells already present in the deep paracor-
tex that would relocalize near HEVs, but instead by incom-
ing T cells that exit from the HEVs and accumulate around
Ag-presenting DCs.
 
Initial Activation Clusters Are Constituted by DCs and T
Cells.
 
To ensure that the clusters of 3A9 T cells observed
in primed mice are indeed constituted by T cells and Ag-
Figure 3. CD4  T cells cluster around
Ag-loaded DCs in the outer paracortex of
draining LNs. (a) Mice were primed by sub-
cutaneous injection of BSA-coupled fluo-
rescent microspheres. Draining LNs from
five mice were harvested 24 h later and the
expression of CD11c, CD11b, and CD8 
was examined by FACS® analysis of total
LN cells or CD11c  cells, as indicated. (b–d)
Mice were adoptively transferred with dye-
labeled 3A9 CD4 T cells and then primed
24 h later with BSA- or HEL-coupled fluores-
cent microspheres, as indicated. Draining LNs
were harvested 24 h (b and c) or 3 d (d) af-
ter immunization. (b) Clustering of 3A9 T
cells (red) with microsphere-positive cells
(green) near the B cell area revealed by anti-
B220 staining (blue) is shown. (c) Phalloidin
staining highlights the tight interaction be-
tween 3A9 T cells (diffuse green staining)
and bead-containing DCs (red dots). (d)
FACS® analysis of CFSE profile of 3A9 T
cells. One experiment out of two (a and c)
or three (b and d) with similar results is
presented.T
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loaded DCs, we coupled the HEL protein or, as control,
BSA directly to fluorescent microspheres. These 40-nm
particles are too big to percolate freely into the LNs (22).
Previous studies have shown that when injected subcutane-
ously, these microspheres are phagocytosed by skin-resi-
dent monocytes that differentiate into DCs and migrate to-
ward draining LNs (23). Indeed, FACS
 
® 
 
analysis of LN
cells of injected mice showed that microsphere-positive
cells expressed CD11c and thus belong to the DC lineage
(Fig. 3 a). In addition, these microsphere-positive cells ex-
pressed CD11b but not B220 or CD8
 
  
 
(Fig. 3 a and not
depicted). Confocal analysis of bead-positive cells indicated
Figure 4. Ag-loaded DCs migrate preferentially near
HEVs. (a) Mice were primed by subcutaneous injec-
tion of BSA-coupled fluorescent microspheres as in
Fig. 3 a. Sections of draining LNs were stained with a
PNAd-specific Ab (A and B, blue) and a CD11c-specific
Ab (B, red), whereas beads appear in green. In C, sec-
tions were stained with the PNAd-specific Ab (white)
and electronic sensitivity was increased to highlight the
reticular network (arrowhead) that surrounds the HEV
(arrow).  160 in A and  200 in B and C. One repre-
sentative experiment out of three performed is shown.
(b and c) BM-derived DCs were CMTMR labeled
(green) and injected into the footpads of mice. LNs
were collected 24 h later and sections were stained
with a PNAd-specific Ab (blue). (b) The percentage of
DCs present inside or outside the deep paracortex de-
fined by the dashed line was calculated as indicated in
Materials and Methods. The mean percentage and SD
of 13 individual LNs is presented. (c) The distance be-
tween each DC and the most proximal HEV was cal-
culated as described in Materials and Methods and the
percentage of DCs within each distance interval was
plotted (histogram). In addition, we defined a proxim-
ity perimeter around the HEV (A and B, arrows) with
a radius of one and one half times the diameter of an
HEV (A and B, refer to Results). The distance intervals
included in this perimeter and the mean percentage  
SD of DCs within that perimeter are indicated on the
histogram.T
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that beads accumulated within cells, suggesting that they
had been phagocytosed and engulfed by CD11c
 
  
 
DCs (not
depicted and Fig. 3 c). Finally, the bead-positive cells de-
tected in the LN paracortex of immunized mice expressed
CD11c and thus belong to the DC lineage (Fig. 4 a, B).
Next, we determined whether bead-containing DCs
clustered with the 3A9 T cells. Therefore, mice were
adoptively transferred with CMTMR-labeled 3A9 T cells
(red) and immunized 24 h later with fluorescent micro-
spheres coupled to HEL or BSA (green). Clustering of the
3A9 T cells was only found in mice immunized with HEL-
coupled microspheres and in that case involved fluorescent
beads (Fig. 3 b, inset). To ensure that 3A9 T cells inter-
acted with bead-loaded DCs, we incubated the sections
with fluorescent phalloidin that binds actin filaments result-
ing in a bright staining of the membrane of all cells within
the LN. In this case the 3A9 T cells were CFSE labeled,
giving a diffuse cytoplasmic green staining and the beads
were red. Close examination of clusters showed that the
3A9 T cells as well as rare endogenous cells surrounded and
interacted with bead-carrying DCs (Fig. 3 c). Finally,
HEL-coupled microspheres were efficient 3A9 T cell acti-
vators (Fig. 3 d).
Collectively, these results suggest that after immuniza-
tion, skin DCs migrate to the draining LN where they in-
teract with and stimulate the Ag-specific T cells near
HEVs. These observations further suggested that homing of
tissue-derived DCs near HEVs may determine the site of T
cell activation.
 
Tissue-derived DCs Home in the Vicinity of HEVs.
 
Be-
cause beads containing DCs interacted with and stimulated
the 3A9 T cells, we used this experimental approach to an-
alyze the localization of skin-derived DCs in immunized
LN. We found that beads accumulated in the subcapsular
sinus that drains the afferent lymph (Fig. 4 a, A). This
bright staining likely corresponds to bead aggregates as ob-
served when soluble protein is injected subcutaneously
(24). In the paracortex, fluorescent beads were found in the
proximity of HEVs where initial activation clusters are lo-
cated (Fig. 4 a, A). In this case, bead-positive cells ex-
pressed CD11c and thus likely correspond to the DCs
identified by FACS
 
® 
 
analysis (Fig. 4 a, B).
Structural analysis have shown that HEVs are surrounded
by a network of fibroblastic reticular cells that wind around
the HEVs forming the paracortical cord (9). We found that
this reticular network is weakly stained with the PNAd-
specific Ab (Fig 4 a, C). It is unclear whether staining re-
sults from stickiness of the fibroblastic reticular cells that in-
vest the reticular fibers or very low levels of expression of
PNAd by these fibers. Nonetheless, this reactivity reveals
the reticular network surrounding the HEV allowing for a
more detailed examination of T cell and DC positioning.
Previous studies have shown that immigrant cells transit
through the cord before getting access to the cavities that
constitute most of the paracortex (9, 25). In agreement, T
cells were found within the paracortical cords and in the
cavities (see Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20030167/DC1). In contrast, bead-loaded
DCs were generally excluded from the cord and primarily
found in the cavities (Fig. 4 a, C). However, some DCs ap-
pear to come into very close contact, lining along the corti-
cal side of the cord (Fig. 4 a, C). Thus, DCs appeared to
home in the very near proximity of HEVs at sites T cells
might take to gain access to the paracortex.
In this experimental set up, quantitative analysis of DC
localization and DC–T cell interactions is complicated by
the fact that only cells that have engulfed several beads are
detected at the low magnification used to visualize an en-
tire LN. In addition, many beads containing DCs might be
missed because beads accumulated in a confined area of the
DC and are thus quite often out of the section plan (Fig.
3 c). To have a more accurate measurement of the process
we analyzed the placement, within LNs, of in vitro–differ-
entiated DCs when injected into the footpad of recipient
mice. At 6 h after footpad injection, CMTMR-labeled
DCs are primarily found in or just beneath the subcapsular
sinus indicating that they access draining LNs by the affer-
ent lymphatics (see Fig. S2, available at http://www.jem.
org/cgi/content/full/jem.20030167/DC1). Then, the DCs
migrate into the LN paracortex where they reside for up
to 48 h (Fig. 4 b and Fig. S2, available at http://www.
jem.org/cgi/content/full/jem.20030167/DC1). The in-
jected DCs did not distribute randomly into the T cell zone
but preferentially homed in the outer paracortex of the
draining LN (Fig. 4 b). Indeed, 77 
 
  
 
7% (mean 
 
  
 
SD, 
 
n 
 
 
 
13) of the LN-homing DCs concentrated in the outer
paracortex of draining LNs. Importantly, most DCs were
still found at this location 48 h after transfer, indicating that
they did not simply pass there on their way to the deep
paracortex (Fig. S2, available at http://www.jem.org/cgi/
content/full/jem.20030167/DC1). We wished to deter-
mine the proportion of injected DCs that may come into
close proximity of the HEV cord. Therefore, we evaluated
by computer analysis the distance between each DC and
the most proximal HEV (Fig. 4 c). Because the cord was
not always clearly visible we defined a proximity perimeter
around the HEVs. On average, the cord has a radius equal
to the diameter of the HEV it surrounds. Thus, we defined
a perimeter around the HEV corresponding to one and one
half times the diameter of the HEV (Fig. 4 c, B). Because
DCs did not enter the paracortical cord (Fig. 4 a, C), this
perimeter around the HEV appeared as a rational estimate
of the HEV most proximal area. We found that 55.8 
 
 
 
8.3% (mean 
 
  
 
SD, 
 
n 
 
  
 
5) of the injected DCs located in
that narrow perimeter, confirming our previous observa-
tions. This result is quite remarkable since DCs migrate
into the node through the afferent lymph and not through
the HEVs (Fig. S2, available at http://www.jem.org/cgi/
content/full/jem.20030167/DC1).
Next, we determined whether in this case too, DCs’
placement conditioned DC–T cell clustering in the outer
paracortex. For this experiment, HEL-loaded or, as con-
trol, PCC-loaded DCs were injected into recipient mice
6 h before transfer of 3A9 T cells. The mice were killed
18 h after T cell transfer and the localization of DC–T cell
clusters was analyzed by confocal microscopy. As expected,T
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HEL-loaded but not PCC-loaded DCs formed numerous
clusters with 3A9 T cells (Fig. 5). Most DC–T cell clusters
were found in the outer paracortex thus matching DCs’ lo-
calization. Indeed, 83 
 
  
 
8% (
 
n 
 
  
 
8) of the clusters involv-
ing labeled DCs and 3A9 T cells were confined to the
outer paracortex in the proximity of HEV (Fig. 5, B). Col-
lectively, these data indicate that cluster formation in the
outer paracortex is determined by DCs’ placement in the
proximity of HEVs.
 
The DCs Located Near HEVs Scan Incoming T Cells.
 
We
wished to further determine whether DCs scan all incoming
T cells and selectively trap T cells expressing a T cell recep-
tor specific for the peptide–MHC complexes they present.
Therefore, we analyzed concomitantly the traffic of nonspe-
cific and specific T cells. Thus, recipient mice were preim-
munized 24 h before adoptive transfer of CFSE-labeled 3A9
T cells (green) and CMTMR-labeled nontransgenic (W)
CD4 T cells (red). Preliminary experiments had shown that
Ag-loaded DCs reach the LN by 8–18 h after immunization
(Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20030167/DC1, not depicted, and reference 24). Un-
der these conditions, Ag-loaded DCs would have homed
appropriately within the LN and recruitment of Ag-specific
T cells within the activation clusters could be examined by
kinetic studies (Fig. 6 a). 10 min after transfer, both 3A9 and
wild-type CD4 T cells were detected within the HEVs of
immunized mice. By 1 h after transfer, both CD4 T cell
populations had crossed the endothelial barrier, remaining
near HEVs in the paracortical zone. While the wild-type
CD4 T cells continued their journey toward the deep para-
cortex, which they reached by 6 h after transfer, the 3A9 T
cells remained and appeared to cluster in the outer paracor-
tex near HEVs. Clustering of 3A9 T cells was already visible
1 h after transfer and clearly evident 6 and 24 h after trans-
fer. As expected, migration of the two populations was
comparable when mice were injected with CFA only (Fig.
6 a). Importantly, at 1 and 6 h after transfer, some wild-type
T cells were found within forming clusters of Ag-specific
3A9 T cells (Fig. 6 a, inset). Colocalization of the two T cell
populations suggests that all incoming T cells pass near DCs
in sufficient proximity to allow TCR–MHC interaction. T
cells expressing a TCR specific for the MHC–peptide com-
plexes presented by the DCs will arrest and establish firm
contact with the DCs. In contrast, nonspecific T cells will
not arrest and continue their journey into the deep paracor-
tex. Scanning of DCs by incoming T cells was also sug-
gested in the previous experiments where few 3A9 T cells
were found to colocalize with PCC-loaded DCs (Fig. 5)
and by recent two photon analysis of DC–T cell interaction
in vivo (13). This kinetics study combined with quantitative
analysis of T cell sojourn in the outer paracortex indicated
that in the absence of Ag, T cells accessed to the deep para-
cortex within 
 
 
 
6 h (Fig. 6 b). At this time point, ingress
and egress seemed to reach some equilibrium so that the dis-
tribution of wild-type CD4 T cells into the outer and deep
paracortex was comparable (Fig. 6 b). In contrast, 82.3 and
76.15% of the 3A9 T cells found in the draining LN were
still present in the outer paracortex at 6 and 24 h after HEL
immunization, respectively (Fig. 6 b). Retention of the 3A9
T cells in the proximity of HEV in the outer paracortex was
further confirmed by statistical analysis of the distance distri-
bution of 3A9 T cells or wild-type T cells with the most
proximal HEV (Fig. 6 c). Thus, 3A9 T cells were preferen-
tially found in the HEV most proximal area where DCs
concentrate whereas wild-type T cells have a more dis-
persed distribution, away from HEVs.
Figure 5. DCs’ placement near HEVs
determine the localization of activation
cluster. BM-derived DCs were pulsed
with PCC or HEL peptide, labeled with
CMTMR (green), and then injected
into the footpads of recipient mice. 6 h
later, CFSE-labeled 3A9 T cells (red)
were adoptively transferred and draining
LNs were collected 18 h after T cell
transfer. The percentage of DC–T cell
clusters in the deep or outer paracortex
of mice injected with HEL-loaded DCs
was measured as in Fig. 4 b. The mean
percentage and SD of eight individual
LNs is presented.T
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Figure 6. DCs scan incoming
CD4 T cells nearby HEVs. (a)
CFSE-labeled 3A9 CD4 T cells
(3A9, green) and CMTMR-
labeled nontransgenic CD4  T
cells (W, red) were coinjected
into recipient mice immunized
24 h earlier with CFA or CFA/
HEL, as indicated. Draining LNs
were harvested at the indicated
time points after adoptive trans-
fer and analyzed by confocal mi-
croscopy after staining with a
PNAd-specific Ab (blue). (b)
The percentage of 3A9 CD4 T
cells present in the outer para-
cortex (outside dashed circle)
was calculated as described in
Materials and Methods. The
mean values and SD of four
(CFA) and at least eight (CFA/
HEL) different nodes analyzed in
one representative experiment
out of three performed are
shown. (c) The minimal distance
between 3A9 (solid bars) or
wild-type (open bars) and the
most proximal HEV was calcu-
lated as in Fig. 4 c and is pre-
sented in the histogram. Red
stars delineate the boundaries of
two distinct areas. In the first
area, most proximal to the HEV
(intervals 4–9), the 3A9 T cells
are more frequent than the wild-
type CD4 T cells. In the second
area (intervals 10–27), more dis-
tant from the HEV, the wild-
type CD4 T cells are more fre-
quent than the 3A9 T cells. The
distribution of 3A9 and wild-
type CD4 T cells are signifi-
cantly different based on a Mann
and Whitney test of results ob-
tained with six distinct LNs. The
percentage of 3A9 or wild-type
T cells within the proximity pe-
rimeter of an HEV was calcu-
lated as in Fig. 4 c and is pre-
sented for the six individual LNs
analyzed.T
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Collectively, these results indicate that tissue-derived
DCs localize near the HEVs where as gatekeepers they scan
incoming T cells and selectively retain and stimulate Ag-
specific T cells. We further show that the placement of
DCs near HEVs allows for an efficient recruitment of Ag-
specific T cells into activation clusters.
 
Discussion
 
In this study, we examined the strategy the immune sys-
tem may have developed to foster T cell–APC interactions
at the initiation of an immune response. We show that ini-
tial T cell activation by Ag-presenting DCs is confined to a
restricted area of the paracortex, in the proximity of HEVs.
We further show that DCs, migrating from the site of im-
munization, preferentially home in the vicinity of HEVs
and may therefore determine the site of T cell activation.
Positioning of DCs next to HEVs permits efficient en-
counter between T cells and DCs. Indeed we found that
most Ag-specific T cells passing the HEV are selectively
trapped by the relevant DCs. This later observation might
be explained by a very organized routing of T cells into the
LN. Thus, as suggested by Gretz et al. (9), T cells, when
leaving the HEVs, may enter into corridors that direct them
through the paracotical cord. These corridors may then
connect to the cavities constituting the paracortex at sites
where DCs would preferentially home. In agreement, we
show that DCs preferentially locate in the cavity lining
along the paracortical cord. Recent two photon micros-
copy and confocal analysis of T cell trafficking into intact
node suggest, however, that T cells move randomly when
leaving the HEVs thus dismissing an organized routing of T
cells through corridors (10–13). Such random motion also
suggests that chemokines are not directing basal T cell
movement (12). It still remains possible, however, that che-
mokines may do so when expressed locally by DCs in im-
munized LNs. Mature DCs express CCL19 and CCL21
and may therefore attract CCR7 expressing incoming naive
and memory T cells (5). Dynamic imaging of T cell traf-
ficking through HEVs under conditions where DCs are de-
ficient for these chemokines should help clarify these issues.
A critical question raised by this model is how DCs de-
cide where to go within the LN. Preferential localization of
DCs in the outer paracortex likely relies on migration and
subsequent arrest of the DCs in these restricted areas of the
LN. Directional migration of the DCs might be imposed in
part by LN organization. After maturation, tissue DCs loose
expression of tissue homing receptor and acquire CCR7
expression, two events that are instrumental for DC migra-
tion to regional LNs (5–8). CCL19 and CCL21 are the two
known CCR7 ligands. Interestingly, expression of these
chemokines is confined to stromal cells mainly residing in
the outer cortex (7, 26). Expression of these chemokines
might therefore target DCs to specific location and contrib-
ute in part to DC arrest, though firm arrest likely involves
additional signals such as carbohydrate interaction with the
collagen fibers of the reticular network. In organized in-
 
flammatory infiltrates, blood-borne DCs also take a perivas-
cular localization further suggesting that DCs’ placement is
tightly regulated (27–29). Interestingly, in this case too, the
DCs proximal to HEVs formed clusters with T cells.
We showed that placement of DCs near HEVs allows for
efficient recruitment of Ag-specific T cells into activation
clusters. Although we have no experimental evidence to
support it, it is tempting to speculate that such placement
optimizes T cell responses. Indeed, the probability of en-
counter of two rare cell types, the relevant DCs and the Ag-
specific T cells, is likely higher when the “searching area” is
limited. This would be the case when DCs are confined
around HEVs and not when they are dispersed in the entire
paracortex densely packed with irrelevant T cells. Such en-
counter might also be improved because the DCs’ chemo-
kine gradient would be higher in proximity of HEVs and
thus more efficient at directing T cell movement. In addi-
tion, placement of DCs near HEVs likely also reduces the
“searching period.” Although T cell velocity within LNs is
high, in the range of 11 
 
 
 
m min
 
 
 
1
 
, scrutinizing the entire
paracortex would be time consuming and therefore might
be detrimental for the host immune response (10–13). Sev-
eral studies have shown that T cell entry within inflamed
LNs is augmented (30, 31, and unpublished data). As a con-
sequence, Ag-specific T cells access the LN draining the in-
fection site more efficiently, thus increasing the likelihood
that rare Ag-specific T cells that are dispersed throughout
the body encounter DCs presenting the Ag of interest.
Therefore, we would propose that increased influx of T
cells into the LNs combined with a strategic location of
DCs at the entry doors of T cells within LNs might be two
critical mechanisms that the immune system has developed
to force relevant T cells and DCs to meet.
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